Literature DB >> 4824211

Thiol groups of normal human immunoglobulin G.

B M Buchwald, G E Connell.   

Abstract

Normal human immunoglobulin G (IgG) was treated with radioactive N-ethylmaleimide in the absence of a reducing agent but in the presence of a denaturing solvent. The sites of reaction were determined by isolation of the radioactive peptides from thermolytic digests of the heavy and light chains. Six radioactive peptides were purified from the digest of the light chain and ten from that of the heavy chain. When sequenced, all the peptides were identical with peptides that would be predicted for the half-cystine residues involved in disulphide bonds. The specific radioactivity of the peptides indicated that the proportion of the half-cystine residues in the reduced form varied from 0.57 to 2.54%. These results indicate that the disulphide bonds of IgG are not completely oxidized. The estimate of 0.2mol of SH group/mol of IgG (Cecil & Stevenson, 1965; Luks & Connell, 1968) can be accounted for if 0.8% of every half-cystine residue of the intrachain bonds was in the reduced form. Variable cysteine residues as have been described in several myeloma proteins must occur extremely infrequently among the immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4824211      PMCID: PMC1166115          DOI: 10.1042/bj1370281

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  ROLE OF THE SULFHYDRYL GROUP IN THE DENATURATION OF HUMAN GAMMA-GLOBULIN.

Authors:  D A GERBER
Journal:  J Immunol       Date:  1964-06       Impact factor: 5.422

2.  THE CHARACTERIZATION OF MODIFIED HUMAN HEMOGLOBIN. I. REACTION WITH IODOACETAMIDE AND N-ETHYLMALEIMIDE.

Authors:  G GUIDOTTI; W KONIGSBERG
Journal:  J Biol Chem       Date:  1964-05       Impact factor: 5.157

3.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

Review 4.  Biosynthesis of antibodies.

Authors:  A R Williamson
Journal:  Nature       Date:  1971-06-11       Impact factor: 49.962

5.  Aggregation of an immunoglobulin fragment by sulfhydryl oxidation.

Authors:  C I Luks; G E Connell
Journal:  Can J Biochem       Date:  1968-08

6.  Alternate positions for the sulphydryl group in -lactoglobulin: the significance for sulphydryl location in other proteins.

Authors:  H A McKenzie; D C Shaw
Journal:  Nat New Biol       Date:  1972-08-02

Review 7.  Strategy and tactics in protein chemistry.

Authors:  B S Hartley
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

8.  Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment.

Authors:  B Frangione; C Milstein; E C Franklin
Journal:  Biochem J       Date:  1968-01       Impact factor: 3.857

9.  Comparison of myoglobins from harbor seal, porpoise, and sperm whale. 3. Isolation and characterization of the tryptic peptides of harbor seal myoglobin.

Authors:  R A Bradshaw; W H Garner; F R Gurd
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

10.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

View more
  2 in total

1.  Cysteinylation of a monoclonal antibody leads to its inactivation.

Authors:  Troy McSherry; Jennifer McSherry; Panfilo Ozaeta; Kenton Longenecker; Carol Ramsay; Jeffrey Fishpaugh; Steven Allen
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

2.  Enzymatic basis of the Fc-selective intra-chain disulfide reduction and free thiol content variability in an antibody produced in Escherichia coli.

Authors:  Tomasz K Baginski; Karthik Veeravalli; Rebekah McKenna; Christopher Williams; Katherine Wong; Christina Tsai; Daniel Hewitt; Karthik Mani; Michael W Laird
Journal:  Microb Cell Fact       Date:  2022-08-19       Impact factor: 6.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.